APUS
Apimeds Pharmaceuticals US, Inc.
Pharmaceutical PreparationsNYSE<br>Emerging growth company
Total Trades
3
Buys
3
Sells
0
Largest Trade
$1M+
Insiders
3
Institutional Funds
5
Inst. Value
$500K+
Activist Filings
3
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Kim Christopher | Chairman and CMO | BUY | $50K–$100K | 28K | $1.83 | May 15, 2025 |
| Koo Jakap | Director | BUY | $50K–$100K | 29K | $1.99 | May 14, 2025 |
| Inscobee Inc. | 10% Owner | BUY | $1M+ | 500K | $4.00 | May 14, 2025 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 5 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Hemenway Trust Co LLC | 274K | $100K–$500K | SH |
| VANGUARD GROUP INC | 35K | $50K–$100K | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 32K | $50K–$100K | SH |
| JANE STREET GROUP, LLC | 27K | $15K–$50K | SH |
| UBS Group AG | 582 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 11, 2026
10.0%
1.4M shares
SC 13D/A · Jan 26, 2026
16.7%
2.1M shares
SC 13D · May 20, 2025
17.5%
2.0M shares